Immucor (BLUD) Slammed On Disappointing Results and Guidance
Tweet
Share
E-mailGet Alerts BLUD Hot Sheet
Join SI Premium – FREE
Shares of Immucor Inc. (Nasdaq: BLUD) are getting hammered in after-hours action following disappoint Q1 results and guidance.
Shares are trading at $16.90, down 17 percent from the close.
Immucor reported Q1 EPS of $0.30, inline with the analyst estimate of $0.30. Revenue for the quarter was $83.6 million, which compares to the estimate of $85.02 million.
The company lowered its FY11 outlook: EPS move from $1.23-$1.29 to $1.08-$1.18, sales move from $345-$355 million to $320-$332 million. The Street is currently looking for FY11 EPS of $1.27 on sales of $351.79 million. Lowers its forecast for echo orders to 140-180.
Shares are trading at $16.90, down 17 percent from the close.
Immucor reported Q1 EPS of $0.30, inline with the analyst estimate of $0.30. Revenue for the quarter was $83.6 million, which compares to the estimate of $85.02 million.
The company lowered its FY11 outlook: EPS move from $1.23-$1.29 to $1.08-$1.18, sales move from $345-$355 million to $320-$332 million. The Street is currently looking for FY11 EPS of $1.27 on sales of $351.79 million. Lowers its forecast for echo orders to 140-180.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Verizon planning new round of layoffs this week - Barron’s
- Susquehanna Starts IBM (IBM) at Neutral
- Molina Healthcare to join S&P MidCap 400, Construction Partners to join S&P SmallCap 600
Create E-mail Alert Related Categories
Insiders' Blog, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
